Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
Year: 2019
Type: article
Source: Current Opinion in Hematology
Authors: Daniel A. Pollyea, Craig T. Jordan
Institution: University of Colorado Anschutz
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2914344069
